Microsoft lays AI sensors for smart farming, cutting-edge healthcare in India - Weekly Voice


The aim is clear: To help the community digitally record information to cut costs and increase yields -- with just a smartphone in their hands as AI leveraged Cloud computing to make sense of the data for farmers. India has now embarked on a journey to bring AI sensors into the fields. For Anant Maheshwari, the company's India President, Microsoft has begun empowering small-holder farmers in India to increase their income through higher crop yield and greater price control. "We are working with farmers, state governments, the Ministry of Electronics and Information Technology (MeitY) and the Ministry of Agriculture and Farmers Welfare to create an ecosystem for AI into farming," Maheshwari told IANS. In some villages in Telangana, Maharashtra and Madhya Pradesh, farmers are receiving automated voice calls that tell them whether their cotton crops are at risk of a pest attack, based on weather conditions and crop stage.

Stephen Hawking warned Artificial Intelligence could end human race


NEW DELHI: Eminent astrophysicist Stephen Hawking, who died today, had warned that the efforts to develop artificial intelligence (AI) and create thinking machines could spell the end of the human race. Hawking, known for his work on black holes and relativity, was regarded as one of the most brilliant theoretical physicists since Albert Einstein. He was suffering from amyotrophic lateral sclerosis, more commonly known as Lou Gehrig's disease since he was 20. Despite being told that he had just two more years to live in 1963, Hawking continued to make path breaking contributions to science till the age of 76. In the last few years, Hawking repeatedly warned about the threat of climate change, artificial intelligence, population burden and hostile aliens.

Google working with Aravind Eye Hospital to train its AI in diabetic retinopathy screening FactorDaily


India's largest eye care provider, Aravind Eye Hospital, has been quietly working for over four years with Google on a project to use artificial intelligence (AI) in ophthalmology. Aravind Eye Hospital, which has branches across India, is headquartered in Madurai, Tamil Nadu. Lily Peng, product manager at Google, who released a paper on the research a year ago, said at the 2017 WIRED Business Conference that Google had just finished a clinical study in India, and that work was underway to get the technology into routine use with patients. India, considered the diabetes capital of the world, has over 70 million diabetes patients who are at risk of blindness due to the disease. India's largest eye care provider, Aravind Eye Hospital, has been quietly working for over three to four years with Google on a project to use artificial intelligence in ophthalmology At the TensorFlow Dev Summit earlier this year, Peng had said that that Google's machine learning algorithm was very close to an ophthalmologist in terms of performance.

Gene-reading software to cut TB diagnosis from months to minutes

New Scientist

A DOCTOR in Mumbai, India, puts a spit sample into a handheld device. The doctor checks the results to see exactly what kind of drug-resistant tuberculosis the person has, and the precise combination of drugs needed to treat it. "If you can identify drug-resistant TB in less than a day, you will massively improve treatment" This is the goal of CRyPTIC, a global project run by a team at the University of Oxford. It aims to speed up the diagnosis and treatment of drug-resistant TB, cutting the wait from months to days, or even minutes. The idea is that the software will prescribe the right medication for TB just by looking at its genome.

Diagnosing early-stage cervical cancer using artificial intelligence


Using an artificial intelligence-based algorithm that uses scattered light data from tissues, researchers from IISER Kolkata and IIT Kanpur have been able to differentiate normal and precancerous tissue, and even identify the different stages of progression of the disease within a few minutes and with great accuracy. In vivo studies are now being carried out.